Doug Hampton

South Korea In-Vitro Diagnostics (IVD) Market Report 2023: A $3.7 Billion Market by 2028

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “South Korea In-Vitro Diagnostics (IVD) Market (By Technology, Application, Product, End User), Size, Share, Major Deals, Key Players Analysis, Government Initiatives, Recent Developments – Forecast to 2028” report has been added to ResearchAndMarkets.com’s offering. South Korea In-Vitro Diagnostics (IVD) market is predicted to reach US$ 3.7 Billion by 2028 … Read more

Formulation Technologies & Platforms, Physical Process Control Methods, Development Factors, Competitive Landscape

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Extended Release Injectable Drugs” report has been added to ResearchAndMarkets.com’s offering. Chronic conditions require drug administration over long periods of time, placing a greater emphasis on self-administration. With the shift away from caregiver interaction, drug safety and compliance/adherence become prominent concerns. These concerns, which are not new, are becoming … Read more

Ipsen acaba de aprovar Bylvay® no Brasil, após a conclusão da aquisição da Albireo

by

A aprovação dessa droga, fruto da aquisição da Albireo,  representa uma oportunidade de crescimento para a Ipsen e reforça o seu posicionamento no mercado de doenças raras São Paulo, 16 de junho de 2023 /PRNewswire/ — A Ipsen acaba de aprovar o Bylvay® (odevixubate) no Brasil e o seu registro foi publicado no Diário Oficial … Read more

Look at more than 550 Drugs in Clinical Trial

by

DUBLIN, June 16, 2023 /PRNewswire/ — The “Global Cancer Antibody Drug Conjugates Market Size, Drug Sales, Drug Dosage, Price, & Clinical Trials Outlook 2029” report has been added to  ResearchAndMarkets.com’s offering. Global Cancer Antibody Drug Conjugates Market Size, Drug Sales, Drug Dosage, Price, & Clinical Trials Outlook 2029 Report Highlights: Global Antibody Drug Conjugates Market Opportunity: … Read more

Cano Health Announces Leadership Change to Advance Execution of Value Creation Plan

by

Mark Kent appointed Interim Chief Executive Officer Dr. Marlow Hernandez has agreed to step down immediately as Chief Executive Officer and remain on the Board of Directors Launches search to identify permanent CEO and to refresh the Board with additional new independent directors MIAMI, June 16, 2023 /PRNewswire/ — Cano Health, Inc. (“Cano Health” or … Read more

SQI Diagnostics Announces Receipt of Intention to Enforce Security from Pivot Financial and Anticipated Voluntary Bankruptcy Filing

by

TORONTO, June 16, 2023 /PRNewswire/ – SQI Diagnostics Inc. (“SQI” or the “Company”) (TSXV: SQD) (OTCQB: SQIDF) today announced that the Company’s board of directors (the “Board“) has received a notice of intention (the “Notice“) to enforce security issued by its senior secured creditor, Pivot Financial I Limited Partnership (“Pivot“), under Section 244(1) of the Bankruptcy and … Read more

Healthcare Trust Announces Preferred Stock Dividends

by

NEW YORK, June 16, 2023 /PRNewswire/ — Healthcare Trust, Inc. (Nasdaq: HTIA / HTIBP) (“HTI”) announced today that it declared quarterly dividends on its outstanding preferred stock. Specifically, HTI declared a dividend of $0.4609375 per share on its 7.375% Series A Cumulative Redeemable Perpetual Preferred Stock (the “Series A Preferred Stock”) payable on July 17, … Read more

Coeptis Therapeutics Holdings, Inc. Announces Closing of $3.5 Million Underwritten Offering

by

WEXFORD, Pa., June 16, 2023 /PRNewswire/ — Coeptis Therapeutics Holdings, Inc. (NASDAQ: COEP) (“Coeptis” or the “Company”), a biopharmaceutical company developing innovative cell therapy platforms for cancer, today announced the closing of an underwritten offering for gross proceeds of approximately $3.5 million to a single healthcare focused investor prior to deducting underwriting discounts and commissions … Read more

China Jo-Jo Drugstores Announced Receipt of Nasdaq Notification Regarding Minimum Bid Price Deficiency

by

HANGZHOU, China, June 16, 2023 /PRNewswire/ — China Jo-Jo Drugstores, Inc. (Nasdaq: CJJD) (“Jo-Jo Drugstores” or the “Company“), a leading online and offline retailer, wholesale distributor of pharmaceutical and other healthcare products and healthcare provider in China, today announced that on June 15, 2023, the Company has received a notification letter from Nasdaq Listing Qualifications … Read more

Evofem Biosciences Announces Financial Results for the First Quarter of 2023

by

— Increased net product revenue 37% in the first quarter of 2023 vs. prior year quarter — — Reduced operating expenses 72% — — Decreased loss from operations by 88% — — Reaffirms path to positive EBITDA — SAN DIEGO, June 16, 2023 /PRNewswire/ — Evofem Biosciences, Inc. (OTCQB: EVFMD) today announced financial results for … Read more